The Horizons Tracker

FEBRUARY 8, 2024

Innovation involves trying out new things, making improvements, and seeing what works in the market. This can make it tough for company leaders to push for innovation. The study found that if that was the case, firms seem to be “more” innovative than normal. “Subordinate managers run the company day to day.

Innovation 109

Innovation Company Short-term Long-term 109

N2Growth Blog

OCTOBER 26, 2023

Moreover, the board’s critical role extends to risk management, ensuring robust processes are in place to identify, assess, and mitigate risks, bolstering the organization’s success trajectory. Such a board is not merely a governance powerhouse but a catalyst for innovation, decision-making sagacity, and long-term sustainability.

Succession 406

Succession Ethics Diversity Objective 406

N2Growth Blog

DECEMBER 26, 2023

They are no longer responsible for managing risk but also for driving innovation, enhancing customer experiences, and achieving sustainable growth. This includes understanding market trends, anticipating risks, and crafting effective risk management strategies.

Insurance 235

Insurance Execution Long-term Diversity 235

Harvard Business Review

JUNE 9, 2017

Legitimate concerns over conflict of interest that have resulted in overly extreme preventative policies are a central cause. It is time for all parties to revisit those policies and replace them with rules that recognize both true conflicts and true confluences of interest. Insight Center. Sponsored by Optum. Research.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10

Harvard Business Review

JUNE 2, 2014

But as Steve Blank, Henry Chesbrough, and others have pointed out , that advantage is offset by the daunting fact that corporate innovators have to fight a war on two fronts. This is where the concept of stealth innovation can help you. To some extent, you can secure the necessary flexibility by negotiating it up front.

Innovation 11

Innovation Conflict of Interest Strategy System 11

Harvard Business Review

SEPTEMBER 12, 2012

Equating "innovative" with new molecules misses the point: to develop clinically superior new medicines. The apparent business model of Big Pharma emphasizes the billions spent at great risk to find "innovative" and "breakthrough" new molecules that must be priced high to recover research costs that have become "unsustainable."

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

JUNE 6, 2012

The secret isn't rocket science — it's a full-time commitment to the art and science of project management. PMI's Pulse of the Profession Survey shows that more than two-thirds of project-based organizations have created a dedicated Project Management Office to lead such efforts. Leveraging Executive Sponsors.

Project 16

Project Survey Budgeting Conflict of Interest 16